AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 1 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | 0.0% | 1,221 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 1,221 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -97.3% | 1,221 | -84.4% | 0.00% | – |
| Q1 2018 | $110,000 | +129.2% | 7,846 | +170.1% | 0.00% | – |
| Q1 2017 | $48,000 | -86.3% | 2,905 | -88.4% | 0.00% | – |
| Q4 2016 | $350,000 | +4.2% | 25,126 | 0.0% | 0.00% | – |
| Q3 2016 | $336,000 | +102.4% | 25,126 | 0.0% | 0.00% | – |
| Q2 2016 | $166,000 | -25.2% | 25,126 | 0.0% | 0.00% | – |
| Q1 2016 | $222,000 | -27.9% | 25,126 | +1.7% | 0.00% | – |
| Q4 2015 | $308,000 | -25.6% | 24,700 | -16.0% | 0.00% | -100.0% |
| Q3 2015 | $414,000 | +1433.3% | 29,405 | +653.0% | 0.00% | – |
| Q2 2015 | $27,000 | -15.6% | 3,905 | 0.0% | 0.00% | – |
| Q1 2015 | $32,000 | – | 3,905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,396,071 | $19,643,000 | 2.25% |
| Boxer Capital, LLC | 525,000 | $7,387,000 | 1.76% |
| Baker Brothers Advisors | 10,934,154 | $153,844,000 | 1.34% |
| EMORY UNIVERSITY | 105,815 | $1,489,000 | 1.32% |
| Ghost Tree Capital, LLC | 300,000 | $4,221,000 | 0.88% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,217 | $2,409,000 | 0.71% |
| NEXTHERA CAPITAL LP | 90,700 | $1,276,000 | 0.56% |
| Eventide Asset Management | 175,000 | $2,462,000 | 0.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 62,085 | $874,000 | 0.15% |
| ASCEND CAPITAL, LLC | 214,328 | $3,017,000 | 0.14% |